Protein Synthesis by the Plant Rootlet as a Target for the Rapid Screening of Anticancer Drugs: The Experimental Model Utilization of the Germination of Lepidium sativum Seeds


Article ID: 7561
Vol 37, Issue 10, 2023
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.20233710.545
Received: 8 November 2023; Accepted: 8 November 2023; Available online: 8 November 2023; Issue release: 8 November 2023

Abstract

Backgrounds: Protein biosynthesis takes place in the ribosome. Some antibiotic and antitumor molecules show more reactivity and affinity with ribosome proteins. These observations encourage the search for protein synthesis inhibitors of targets in the fight against infectious diseases and cancer. This study assessed the utilization of Lepidium sativum (LS) seeds germination in rapidly screening new anticancer candidates for drugs. Methods: Antineoplastic prescribed in the clinic was used at different concentrations in the medium of LS seed germination, and the rootlet length was measured after 72 hours. Results: The results showed that antineoplastics inhibitors of protein synthesis inhibit the germination of seed rootlets whatever their origin: chemicals (R2 = 0.99), antibiotics (R2 = 0.87), or extracts of medicinal plants (R2 = 0.93). The half maximal inhibitory concentration (IC50) obtained was close to that of cancer cell lines. Conclusion: To our knowledge. This is the first demonstration that utilization of seed germination of LS might be used for the rapid screening of new antineoplastics candidates.


Keywords

screening;antineoplastics inhibitors;Lepidium sativum rootlet germination;anticancer;antibiotic;new drugs candidate


References

Supporting Agencies



Copyright (c) 2023




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).